Pharsight

1. Orserdu patents expiration

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8399520	STEMLINE THERAP	Selective estrogen receptor modulator	Dec, 2023 (2 months from now)
US7612114	STEMLINE THERAP	Selective estrogen receptor modulator	Aug, 2026 (2 years from now)
US10385008	STEMLINE THERAP	Polymorphic forms of RAD1901-2HCL	Jan, 2038 (14 years from now)
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10071066	STEMLINE THERAP	Method of treating cancer using selective estrogen receptor modulators	Oct, 2034 (11 years from now)
US10420734	STEMLINE THERAP	Method of treating cancer using selective estrogen receptor modulators	Oct, 2034 (11 years from now)
US10745343	STEMLINE THERAP	Polymorphic forms of RAD1901-2HCl	Jan, 2038 (14 years from now)